MacCarthy, E. P.; Bloomfield, S. S. (1983-08-01). «Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects». Pharmacotherapy3 (4): 193–219. doi:10.1002/j.1875-9114.1983.tb03252.x. ISSN0277-0008. PMID6310529.
Lund-Johansen, P. (1988-01-01). «Hemodynamic effects of beta-blocking compounds possessing vasodilating activity: a review of labetalol, prizidilol, and dilevalol». Journal of Cardiovascular Pharmacology11 Suppl 2: S12–17. doi:10.1097/00005344-198800000-00004. ISSN0160-2446. PMID2464093.
MacCarthy, E. P.; Bloomfield, S. S. (1983-08-01). «Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects». Pharmacotherapy3 (4): 193–219. doi:10.1002/j.1875-9114.1983.tb03252.x. ISSN0277-0008. PMID6310529.
Lund-Johansen, P. (1988-01-01). «Hemodynamic effects of beta-blocking compounds possessing vasodilating activity: a review of labetalol, prizidilol, and dilevalol». Journal of Cardiovascular Pharmacology11 Suppl 2: S12–17. doi:10.1097/00005344-198800000-00004. ISSN0160-2446. PMID2464093.
MacCarthy, E. P.; Bloomfield, S. S. (1983-08-01). «Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects». Pharmacotherapy3 (4): 193–219. doi:10.1002/j.1875-9114.1983.tb03252.x. ISSN0277-0008. PMID6310529.
Lund-Johansen, P. (1988-01-01). «Hemodynamic effects of beta-blocking compounds possessing vasodilating activity: a review of labetalol, prizidilol, and dilevalol». Journal of Cardiovascular Pharmacology11 Suppl 2: S12–17. doi:10.1097/00005344-198800000-00004. ISSN0160-2446. PMID2464093.